More dry powder for Newpath’s company creation strategy

With seven biotechs launched through its debut fund, Newpath is looking to expand its portfolio of academic-driven start-ups with its $350 million second fund.

Newpath Partners’ new vehicle is nearly double the size of its $187 million Newpath Partners Fund I, which closed in 2018...